AN2 Therapeutics (ANTX) Shares Issued (2021 - 2026)

AN2 Therapeutics (ANTX) has 6 years of Shares Issued data on file, last reported at $4.2 million in Q1 2026.

• On a quarterly basis, Shares Issued fell 26.26% year-over-year to $4.2 million in Q1 2026; TTM through Mar 2026 was $4.2 million, a 26.26% decrease from a year earlier, with the FY2025 full-year figure at $5.5 million, up 11.76% from the prior year.
• Shares Issued for Q1 2026 stood at $4.2 million, down from $5.5 million in the prior quarter.
• Over the last five years, Shares Issued for ANTX reached as high as $5.7 million in Q1 2025 and fell as low as $450581.0 in Q1 2022.
• Historically, Shares Issued has averaged $3.2 million across 5 years, with a median of $2.8 million in 2022.
• On a YoY basis, Shares Issued climbed as much as 372.54% in 2023 and fell as far as 43.97% in 2023.
• Year by year, Shares Issued stood at $2.8 million in 2022, then jumped by 40.56% to $3.9 million in 2023, then advanced by 24.44% to $4.9 million in 2024, then grew by 11.76% to $5.5 million in 2025, then retreated by 22.57% to $4.2 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $4.2 million in Q1 2026, $5.5 million in Q4 2025, and $5.6 million in Q3 2025.